Publications

Publishing the Frontiers of Immuno-Oncology

Spotlight Publication

Botensilimab (Fc-enhanced anti-CTLA-4), Balstilimab (PD-1 inhibitor)

Emerging survival plateaus with botensilimab and balstilimab: Pan tumor data from a large phase 1b trial of advanced solid tumors

Oct 17, 2025
,
Gordon et al.
ESMO
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Clinical Trials
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
QS-21 STIMULON™ Adjuvant

Efficacy of RTS,S/AS01E Vaccine Against Malaria in Children 5 to 17 Months of Age.

Other Articles & Publications
New England Journal of Medicine
June 2, 2022
,
Bejon, et al.
No items found.
QS-21 STIMULON™ Adjuvant

Recent Clinical Experience With Vaccines Using MPL- And QS-21-Containing Adjuvant Systems.

Other Articles & Publications
Expert Review of Vaccines
June 2, 2022
,
Garçon, et al.
No items found.
QS-21 STIMULON™ Adjuvant

Safety and Immunogenicity of Long HSV-2 Peptides Complexed with rhHsc70 in HSV-2 Seropositive Persons.

Other Articles & Publications
Vaccine
June 2, 2022
,
Wald, et al.
No items found.
QS-21 STIMULON™ Adjuvant

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children.

Other Articles & Publications
New England Journal of Medicine
June 2, 2022
,
RTS,S Clinical Trials Partnership, et al.
No items found.
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 (781) 674 4400 | F: +1 (781) 674 4200